%0 Journal Article
%T Imaging in Patients with Merkel Cell Carcinoma
%A Elisabeth Enzenhofer
%A Philipp Ubl
%A Christian Czerny
%A Boban M. Erovic
%J Journal of Skin Cancer
%D 2013
%I Hindawi Publishing Corporation
%R 10.1155/2013/973123
%X Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine tumor of the skin with a mortality rate of approximately 25% (Peloschek et al., 2010). Accurate assessment of nodal involvement in patients with MCC predicts significantly overall outcome (Smith et al., 2012 and Ortin-Perez et al., 2007). Due to the rarity of this highly aggressive disease, only a few imaging reports on MCC were published, and subsequently still to date no accepted imaging algorithm for MCC is available. For primary staging of MCC, general recommendations have included ultrasonography, chest X-ray CT, and MRI, but recent articles show that the use of sentinel node and FDG-PET/PET-CT is gaining more and more importance. 1. Introduction and Overview Merkel cell carcinoma is a rare and highly aggressive neuroendocrine tumor of the skin. It develops predominantly on sun-exposed area of the head and neck [1, 2]. In 1972, Toker described an unknown, trabecular carcinoma of the skin in five caucasian patients [3]. In 1982, Tang and Toker proposed that the MCC derives from the Merkel cell, a mechanoreceptor of the hair follicle [3, 4]. MCC typically develops rapidly and manifests as firm, nontender, dome-shaped red, purple or violet nodule [5, 6]. The overlying skin is smooth and shiny, sometimes exhibiting ulcerative, acneiform, or telangiectatic features [5, 7]. MCC tends to metastasize to the regional nodes and in 50% of the patients it spreads hematogenously to other organs [8], that is, the liver, bone, brain, and lung [2]. In 1993, Haag and colleagues defined a commonly used staging system [2, 9]: stage I is defined by local disease without lymph node involvement or distant metastases, in stage II carcinoma has spread to lymph nodes but no systemic metastases are detectable, and in stage III distant metastases are detectable [9]. Diagnosis of MCC can be challenging because in many cases MCC lesions mimic benign skin lesions [10]. Unfortunately, in clinical practice, lesions highly suspicious for Merkel cell carcinoma are often biopsied or nonaccurately resected with close margins [2]. In fact, patients presenting with unclear new skin lesions should undergo clinical examination, and lesion still highly suspicious for Merkel cell carcinoma should be excised with clear and wide margins. Diagnosis and management of nodal metastasis in patients without a primary tumor can be challenging. In particular MCC metastasis can mimic metastasis from other small cell neoplasms, that is, for example lung carcinoma [3, 11]. In 2%¨C19% of the patients no primary tumor can be found¡ªdefined as
%U http://www.hindawi.com/journals/jsc/2013/973123/